Headillu

Media Seminar on stroke prevention in atrial fibrillation

Background information for medical media outside the US only

Disclaimer

The content of the website has been cleared by Boehringer Ingelheim GmbH in compliance with the legal provisions applicable for German companies. Such provisions vary from country to country and can have an impact on the information we can provide to you.

Thus, please contact us directly in case further information is requested which takes into account the framework in your home country.

cContact

20 April 2009

Patients at the heart of advances in anticoagulation therapy:
Educational seminar on stroke prevention in atrial fibrillation

Educational seminar on stroke prevention in atrial fibrillation
Media event:

Leading medical experts and patients who are living with atrial fibrilation provide insight into the limitations of current anticoagulation therapy and the impact this has on patients, carers and doctors. Further an update on the development of dabigatran etexilate and its potential to transform stroke prevention and other important therapy areas is given.

Venue:

Boehringer Ingelheim Corporate Headquarters, Ingelheim, Germany
20 April 2009, 14:00 - 17:00 (CET)

Webcast Access
Webcast:

Webcast access

Media contact

  • Boehringer Ingelheim GmbH

    Corporate Division Communications
    Dr Reinhard Malin
    55216 Ingelheim
    Germany

    • Phone + 49 - 6132 – 77 90815
    • Fax + 49 - 6132 – 77 6601
    • contact
    • vCard

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

subscribe to RSS Feed